Begin main content

Natalizumab

Last Updated: May 6, 2008
Result type: Reports
Project Number: S0133
Product Line: Common Drug Review

Generic Name: Natalizumab

Brand Name: Tysabri

Manufacturer: Biogen Idec Canada Inc.

Indications: Multiple Sclerosis, relapsing-remitting

Submission Type: Resubmission

Project Status: Complete

Date Recommendation Issued: February 25, 2009

Recommendation Type: List with clinical criteria and/or conditions